Header Logo

Connection

SARAH SARTAIN to Prognosis

Back to Details
This is a "connection" page, showing publications SARAH SARTAIN has written about Prognosis.
SARAH SARTAIN
Connection Strength
0.064
Prognosis
  1. The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy. Pediatr Blood Cancer. 2020 03; 67(3):e28070.
    View in: PubMed
    Score: 0.048
  2. Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic Microangiopathy. Transplant Cell Ther. 2023 Nov; 29(11):685.e1-685.e7.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.